Preliminary proteomic analysis of indomethacin's effect on tumor transplanted with colorectal cancer cell in nude mice

Journal of Biochemistry and Molecular Biology

Volumn 39, Issue 2, 2006, Pages 171-177

  Wang, Yu Jie ^a   Zhang, Gui Ying ^a   Xiao, Zhi Qiang ^b   Wang, Hong Mei ^a   Chen, Zhu Chu ^b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Colorectal cancer; Indomethacin; Matrix assisted laser desorption ionization mass spectrometry; Two dimensional gel electrophoresis

Indexed keywords

MUS MUSCULUS;

EID: 33645295737     PISSN: 12258687     EISSN: 12258687     Source Type: Journal    
DOI: 10.5483/bmbrep.2006.39.2.171     Document Type: Article

References (32)

1. Al-Saleem, T., Sabri, A. Z. and Qassab, M. (1980) Skin cancers in xeroderma pigmentosum: response to indomethacin and steroids. Lancet 2, 264-265.
2. Barondes, S. H., Castronovo, V., Cooper, D. N., Cummings, R. D., Drickamer, K., Feizi, T., Gift, M. A., Hirabayashi, J., Hughes, C. and Kasai, K. (1994a) Galectins: A family of animal beta-galactoside-binding lectins. Cell 76, 597-598.
3. Barondes, S. H., Cooper, D. N. W., Gitt, M. A. and Leffler, H. (1994b) Galectins: Structure and function of a large family of animal lectins. J. Biol. Chem. 269, 20807-20810.
4. Brockstedt, E., Otto, A., Rickers, A., Bommert, K. and Wittmann-Liebold, B. (1999) Preparative high-resolution two-dimensional electrophoresis enables the identification of RNA polymerase B transcription factor 3 as an apoptosis-associated protein in the human BL60-2 Burkitt lymphoma cell line. J. Protein Chem. 18, 225-231.
5. Candiano, G., Bruschi, M., Musante, L., Santucci, L., Ghiggeri, G. M., Carnemolla, B., Orecchia, P., Zardi, L. and Righetti, P. G. (2004) Blue silver: A very sensitive colloidal Coomassie G-250 staining for proteome analysis. Electrophoresis 25, 1327-1333.
6. Coussens, L. M. and Werb, Z. (2002) Inflammation and cancer. Nature 420, 19-26.
7. Eberhart, C. E., Coffey, R. J., Radhika, A., Giardiello, F. M., Ferrenbach, S. and DuBois, R. N. (1994) Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 107, 1183-1188.
8. Garcia-Rodrigez, L. A. and Huerta-Alvarez, C. (2000) Reduced incidence of colorectal adenoma among long-term users of nonsteroidal anti-inflammatory drugs: A pooled analysis of published studies and a new population-based study. Epidemiology 11, 376-381.
9. Hanif, R., Pittas, A., Feng, Y., Koutsos, M. I., Qiao, L., Staiano-Coico, L., Shiff, S. I. and Rigas B. (1996) Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin independent pathway. Biochem. Pharmacol. 52, 237-245.
10. He, T. C., Chan, T. A., Vogelstein, B. and Kinzler, K. W. (1999) PPAR delta is an APC-regulated target of nonsteroidal anti-inflammatory drugs. Cell 99, 335-345.
11. Hida, T., Leyton, J., Makheja, A. N., Ben-Av, P., Hla, T., Martinez, A., Mulshine, J., Malkani, S., Chung, P. and Moody, T. W. (1998) Non-small cell lung cancer cycloxygenase activity and proliferation are inhibited by non-steroidal anti-inflammatory drugs. Anticancer Res. 18, 775-782.
12. Kinzler, A. K. and Vogelstein, B. (1998) Colorectal tumors; in: The genetic basis of human cancer, Vogelstein, B. and Kinzler, K. W. (eds.), pp. 565-587. McGraw-Hill, New York, USA.
13. Kundu, N., Smyth, M. J., Samsel, L. and Fulton, A. M. (2002) Cyclooxygenase inhibitors block cell growth, increase ceramide and inhibit cell cycle. Breast Cancer Res. Treat. 76, 57-64.
14. Lahm, H., Andre, S., Hoeflich, A., Fischer, J. R., Sordat, B., Kaltner, H., Wolf, E. and Gabius, H. J. (2001) Comprehensive galectin fingerprinting in a panel of 61 human tumor cell lines by RT-PCR and its implications for diagnostic and therapeutic procedures. J. Cancer Res. Clin. Oncol. 127, 375-386.
15. Liu, F. T., Patterson, R. J. and Wang, J. L. (2002) Intracellular functions of galectins. Biochim. Biophys. Acta. 1572, 263-273.
16. Lundholm, K., Gelin, J., Hyltander, A., Lonnroth, C., Sandstrom, R., Svaninger, G., Korner, U., Gulich, M., Karrefors, I. and Norli, B. (1994) Anti-inflammatory treatment may prolong survival in undernourished patients with metastatic solid tumors. Cancer Res. 54, 5602-5606.
17. Panje, W. R. (1981) Regression of head and neck carcinoma with a prostaglandin-synthesis inhibitor. Arch. Otolaryngol. 107, 658-663.
18. Pelzmann, M., Thurnher, D., Gedlicka, C., Martinek, H. and Knerer, B. (2004) Nimesulide and indomethacin induce apoptosis in head and neck cancer cells. J. Oral Pathol. Med. 33, 607-613.
19. Perillo, N. L., Marcus, M. E. and Baum, L. G. (1998) Galectins: Versatile modulators of cell adhesion, cell proliferation, and cell death. J. Mol. Med. 76, 402-412.
20. Perillo, N. L., Pace, K. E., Seilhamer, J. J. and Baum, L. G. (1995) Apoptosis of T cells mediated by galectin-1. Nature 378, 736-739.
21. Rabinovich, G. A., Baum, L. G., Tinari, N., Paganelli, R., Natoli, C., Liu, F. T. and Iacobelli, S. (2002) Galectins and their ligands: amplifiers, silencers or tuners of the inflammatory response? Trends Immunol. 23, 313-320.
22. Rubinstein, N., Alvarez, M. and Zwirner, N. W. (2004) Targeted inhibition of galectin-1 gene expression in tumor cells results in heightened T cell-mediated rejection: A potential mechanism of tumor-immune privilege. Cancer Cell. 5, 241-251.
23. Sanjuan, X., Fernandez, P. L., Castells, A., Castronovo, V., van den Brule, F., Liu, F. T., Cardesa, A. and Campo, E. (1997) Differential expression of galectin 3 and galectin 1 in colorectal cancer progression. Gastroenterology 113, 1906-1915.
24. Sawaoka, H., Kawano, S., Tsuji, S., Tsujii, M., Murata, H. and Hori, M. (1998) Effects of NSAIDs on proliferation of gastric cancer cells in vitro: Possible implication of cyclooxygenase-2 in cancer development. J. Clin. Gastroenterology 27, 47-52.
25. Smith, M. L., Hawcroft, G., Hull and M. A. (2000) Effect of nonsteroidal anti-inflammatory drugs on human colorectal cancer cells: Evidence of differant mechanisms of action. Eur. J. Cancer 36, 664-674.
26. Sonnenberg, A. and Fennerty, M. B. (2003) Medical decision analysis of chemoprevention against esophageal adenocarcinoma. Gastroenterology 124, 1758-1766.
27. Stevenson, M. A., Zhao, M. J., Asea, A., Coleman, C. N. and Calderwood, S. K. (1999) Salicylic acid and aspirin inhibit the activity of RSK2 kinase and repress RSK2-depedent transcription of cyclic AMP response element binding protein and NF-kκB responsive genes. J. Immunol. 163, 5608-5616.
28. Waddell, W. R. and Gerner, R. E. (1980) Indomethacin and ascorbate inhibit desmoid tumors. J. Surg. Oncol. 15, 85-90.
29. Wang, H. M. and Zhang, G. Y. (2005) Indomethacin suppresses growth of colon cancer via inhibition of angiogenesis in vivo. World J. Gastroenterol. 11, 340-343.
30. Williams, C. S., Watson, A. J., Sheng, H., Helou, R., Shao, J. and DuBois, R. N. (2000) Celecoxib prevents tumor growth in vivo without toxicity to normal gut: Lack of correlation between in vitro and in vivo models. Cancer Res. 60, 6045-6051.
31. Yang, R. Y. and Liu, F. T. (2003) Galectins in cell growth and apoptosis. Cell Mol. Life Sci. 60, 267-276.
32. Zhang, X., Morham, S. G., Langenbach, R. and Young, D. A. (1999) Malignant transformation and anti-neoplastic action of nonsteroidal anti-inflammatory drugs (NSAIDs) on cyclooxygenase-null embryo fibroblasts. J. Exp. Med. 190, 451-459.